Re-purposed drive-through vaccination set-up for Mpox, New York Metropolitan Area

Marina Keller; Vishnu Chaturvedi; Rebecca Glassman; Donald S Chen; Marc El-Khoury; Mary Dundas; Nicholas Feola; Varghese Thankachen; Marie Yezzo; Keri Tone; Justin Williams; Renee Garrick

doi:10.1016/j.infpip.2023.100316

Re-purposed drive-through vaccination set-up for Mpox, New York Metropolitan Area

Infect Prev Pract. 2023 Nov 2;5(4):100316. doi: 10.1016/j.infpip.2023.100316. eCollection 2023 Dec.

Affiliation

¹ Westchester Medical Center, 100 Woods Street, Valhalla, NY 10595, USA.

Abstract

Background: This report details how one large medical center in the Metropolitan New York area re-purposed a drive-through COVID-19 vaccination structure to handle a surge in Mpox cases in July 2022.Methods/Results: Simultaneous to on-going COVID -19 vaccination and testing, Mpox vaccination was rolled out in the same drive through structure. More than 1,820 Jynneos (Smallpox and Monkeypox Vaccine, Live, Non-replicating) vaccine dosages were delivered subcutaneously and then intradermally to 1,123 individuals through the open window of their vehicles, averaging 8-10 patients an hour. Five vaccine recipients suffered Mpox rash; there was no exposure among healthcare providers.

Conclusion: Drive-through vaccination is an efficient model to be redeployed for future unexpected vaccine initiatives.

Keywords: Epidemic surge; Intradermal; Jynneos; Monkeypox; Mpox; Vaccine drive-through.